Filtronic has been downgraded to a sell rating despite operational improvements and diversification beyond SpaceX. While customer concentration decreased and new contracts and capacity expansions were achieved in FY2026, adjusted EBITDA fell 34% and margins tightened to around 20%. The FY2027 outlook depends on successful ramp-up of GaN E-band technology, doubling defense revenue, and further customer diversification, but risks from execution and dilution remain high. Projected sales and EBITDA growth through 2028 offer limited upside, with meaningful returns expected only after 2028.
Synchrony Financial has partnered with OpenAI to integrate AI models into its consumer portals, aiming to improve online shopping experiences. This early-stage collaboration will help customers discover products, pay, earn rewards, and build loyalty ...
South Korea's Kbank, the country's first internet-only bank, has officially partnered with Ripple to pilot blockchain-based cross-border remittances, focusing on corridors like Korea-UAE and Korea-Thailand. This partnership aims to replace traditiona...
Rosen Law Firm is investigating potential securities claims against Barclays PLC following reports that Barclays may have provided misleading business information related to its exposure to a collapsed UK mortgage lender, Market Financial Solutions L...
Disc Medicine received a Complete Response Letter from the FDA on February 13, 2026, rejecting its new drug application for bitopertin due to uncertainties requiring more evidence. This news caused the company's stock to fall 22% the same day. The Ro...
Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. This legal inquiry could impact shareholders of the company if wrongdoing is found. Investors currently holding Manhatt...
